BMC gastroenterology
Tumor growth rate for prognostic stratification and treatment optimization in unresectable hepatocellular carcinoma treated with TACE combined with systemic therapy.
Guobin Chen, Meixia Wang, Xing Huang, Zhenzhen Zhang, Yanfang Wu, Xiaochun Chen, Xinkun Guo, Susu Zheng, Tanghui Zheng, Hong Chen, Jingfang Wu, Boheng Zhang
Published: 202610.1186/s12876-025-04596-2
Abstract
BACKGROUND: Tumor growth rate (TGR) is a dynamic biomarker for evaluating therapeutic response and prognosis in unresectable hepatocellular carcinoma (uHCC) with triple therapy, yet its clinical utility and role in guiding treatment optimization requ…
Preview only. Read the full abstract at the source